4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The efficacy and safety of tavaborole, a novel, boron-based pharmaceutical agent: phase 2 studies conducted for the topical treatment of toenail onychomycosis.

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To assess the potential efficacy, safety, and optimal dosing concentration of tavaborole, a novel, boron-based pharmaceutical agent with broad-spectrum antifungal activity, for the treatment of onychomycosis of the toenail due to dermatophytes.

          Related collections

          Author and article information

          Journal
          J Drugs Dermatol
          Journal of drugs in dermatology : JDD
          1545-9616
          1545-9616
          Sep 2014
          : 13
          : 9
          Article
          S1545961614P1124X
          25226015
          b6df6f97-5b54-48f6-9ef6-e705bac28bd1
          History

          Comments

          Comment on this article